Genomic aberrations relate early and advanced stage ovarian cancer.

Cellular Oncology (Dordrecht)
Afra ZaalEORTC GCG Translational Research Group

Abstract

Because of the distinct clinical presentation of early and advanced stage ovarian cancer, we aim to clarify whether these disease entities are solely separated by time of diagnosis or whether they arise from distinct molecular events. Sixteen early and sixteen advanced stage ovarian carcinomas, matched for histological subtype and differentiation grade, were included. Genomic aberrations were compared for each early and advanced stage ovarian cancer by array comparative genomic hybridization. To study how the aberrations correlate to the clinical characteristics of the tumors we clustered tumors based on the genomic aberrations. The genomic aberration patterns in advanced stage cancer equalled those in early stage, but were more frequent in advanced stage (p = 0.012). Unsupervised clustering based on genomic aberrations yielded two clusters that significantly discriminated early from advanced stage (p = 0.001), and that did differ significantly in survival (p = 0.002). These clusters however did give a more accurate prognosis than histological subtype or differentiation grade. This study indicates that advanced stage ovarian cancer either progresses from early stage or from a common precursor lesion but that they do not arise f...Continue Reading

References

Apr 5, 2000·Molecular Pathology : MP·M M WeissP J van Diest
Jan 17, 2003·Journal of the National Cancer Institute·J Baptist TrimbosUNKNOWN EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neop
Apr 28, 2004·The American Journal of Pathology·Ie-Ming Shih, Robert J Kurman
Oct 7, 2004·American Journal of Obstetrics and Gynecology·Jurgen M J PiekRené H M Verheijen
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
May 10, 2005·Bioinformatics·Mark A van de WielBauke Ylstra
Aug 2, 2006·BMC Cancer·Jozien HellemanEls M J J Berns
Feb 3, 2007·Bioinformatics·Mark A van de WielBauke Ylstra
Dec 25, 2007·Biostatistics·Wessel N Van WieringenBauke Ylstra
Mar 11, 2008·Gynecologic Oncology·Mehee ChoiSamuel J Wang
Jul 30, 2008·Genes, Chromosomes & Cancer·Tineke E BuffartBauke Ylstra
Mar 5, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Margaretha AkesonGyörgy Horvath
Mar 12, 2009·Bioinformatics·Mark A van de WielBauke Ylstra
May 7, 2010·Journal of the National Cancer Institute·Baptist TrimbosAntonio Casado
Jun 23, 2010·BMC Bioinformatics·Ilari ScheininBauke Ylstra
Jul 2, 2010·The Journal of Pathology·Rebecca P M BrosensBauke Ylstra
Sep 21, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Leen VerleyeIgnace Vergote
Jun 16, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Serge J SmeetsBauke Ylstra

❮ Previous
Next ❯

Citations

Apr 23, 1990·Biochimica Et Biophysica Acta·D HendriksM van Sande
Jul 6, 2014·Clinical Proteomics·Emily S Boja, Henry Rodriguez
Dec 17, 2016·Cellular Oncology (Dordrecht)·Khalid El BairiMariam Amrani
Feb 28, 2018·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Manish KumarRosy Mondal
Nov 21, 2018·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Feng WangJianyu Liu

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE24418

Methods Mentioned

BETA
biopsies
PCR

Software Mentioned

R
SPSS

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.